138 related articles for article (PubMed ID: 37657572)
1. Double knockout of FFAR4 and FGF21 aggravates metabolic disorders in mice.
Wei L; Ye X; Cui S; Li D; Zhu S
Int J Biol Macromol; 2023 Dec; 253(Pt 1):126553. PubMed ID: 37657572
[TBL] [Abstract][Full Text] [Related]
2. The Regulatory Role of the Central and Peripheral Serotonin Network on Feeding Signals in Metabolic Diseases.
Nonogaki K
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163521
[TBL] [Abstract][Full Text] [Related]
3. YIPF6 controls sorting of FGF21 into COPII vesicles and promotes obesity.
Wang L; Mazagova M; Pan C; Yang S; Brandl K; Liu J; Reilly SM; Wang Y; Miao Z; Loomba R; Lu N; Guo Q; Liu J; Yu RT; Downes M; Evans RM; Brenner DA; Saltiel AR; Beutler B; Schnabl B
Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15184-15193. PubMed ID: 31289229
[TBL] [Abstract][Full Text] [Related]
4. Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21.
Li Y; Wong K; Giles A; Jiang J; Lee JW; Adams AC; Kharitonenkov A; Yang Q; Gao B; Guarente L; Zang M
Gastroenterology; 2014 Feb; 146(2):539-49.e7. PubMed ID: 24184811
[TBL] [Abstract][Full Text] [Related]
5. The hepatokine FGF21 is crucial for peroxisome proliferator-activated receptor-α agonist-induced amelioration of metabolic disorders in obese mice.
Goto T; Hirata M; Aoki Y; Iwase M; Takahashi H; Kim M; Li Y; Jheng HF; Nomura W; Takahashi N; Kim CS; Yu R; Seno S; Matsuda H; Aizawa-Abe M; Ebihara K; Itoh N; Kawada T
J Biol Chem; 2017 Jun; 292(22):9175-9190. PubMed ID: 28404815
[TBL] [Abstract][Full Text] [Related]
6. Endogenous FGF21-signaling controls paradoxical obesity resistance of UCP1-deficient mice.
Keipert S; Lutter D; Schroeder BO; Brandt D; Ståhlman M; Schwarzmayr T; Graf E; Fuchs H; de Angelis MH; Tschöp MH; Rozman J; Jastroch M
Nat Commun; 2020 Jan; 11(1):624. PubMed ID: 32005798
[TBL] [Abstract][Full Text] [Related]
7. Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21.
Camporez JP; Asrih M; Zhang D; Kahn M; Samuel VT; Jurczak MJ; Jornayvaz FR
J Endocrinol; 2015 Sep; 226(3):207-17. PubMed ID: 26203166
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast Growth Factor 21 (Fgf21) Gene Expression Is Elevated in the Liver of Mice Fed a High-Carbohydrate Liquid Diet and Attenuated by a Lipid Emulsion but Is Not Upregulated in the Liver of Mice Fed a High-Fat Obesogenic Diet.
Hao L; Huang KH; Ito K; Sae-Tan S; Lambert JD; Ross AC
J Nutr; 2016 Feb; 146(2):184-90. PubMed ID: 26764334
[TBL] [Abstract][Full Text] [Related]
9. Hydrodynamic delivery of FGF21 gene alleviates obesity and fatty liver in mice fed a high-fat diet.
Gao M; Ma Y; Cui R; Liu D
J Control Release; 2014 Jul; 185():1-11. PubMed ID: 24747761
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
[TBL] [Abstract][Full Text] [Related]
11. Dietary induction of obesity and insulin resistance is associated with changes in Fgf21 DNA methylation in liver of mice.
Geißler C; Krause C; Neumann AM; Britsemmer JH; Taege N; Grohs M; Kaehler M; Cascorbi I; Lewis AG; Seeley RJ; Oster H; Kirchner H
J Nutr Biochem; 2022 Feb; 100():108907. PubMed ID: 34801693
[TBL] [Abstract][Full Text] [Related]
12. FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.
Mottillo EP; Desjardins EM; Fritzen AM; Zou VZ; Crane JD; Yabut JM; Kiens B; Erion DM; Lanba A; Granneman JG; Talukdar S; Steinberg GR
Mol Metab; 2017 Jun; 6(6):471-481. PubMed ID: 28580278
[TBL] [Abstract][Full Text] [Related]
13. Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway.
Wu YK; Ren ZN; Zhu SL; Wu YZ; Wang G; Zhang H; Chen W; He Z; Ye XL; Zhai QX
Acta Pharmacol Sin; 2022 Jun; 43(6):1473-1483. PubMed ID: 34654875
[TBL] [Abstract][Full Text] [Related]
14. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders.
Chen Z; Wang GX; Ma SL; Jung DY; Ha H; Altamimi T; Zhao XY; Guo L; Zhang P; Hu CR; Cheng JX; Lopaschuk GD; Kim JK; Lin JD
Mol Metab; 2017 Aug; 6(8):863-872. PubMed ID: 28752050
[TBL] [Abstract][Full Text] [Related]
15. Probiotic culture supernatant improves metabolic function through FGF21-adiponectin pathway in mice.
Liu Q; Liu Y; Li F; Gu Z; Liu M; Shao T; Zhang L; Zhou G; Pan C; He L; Cai J; Zhang X; Barve S; McClain CJ; Chen Y; Feng W
J Nutr Biochem; 2020 Jan; 75():108256. PubMed ID: 31760308
[TBL] [Abstract][Full Text] [Related]
16. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
[TBL] [Abstract][Full Text] [Related]
17. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
[TBL] [Abstract][Full Text] [Related]
18. Elevated Fibroblast growth factor 21 (FGF21) in obese, insulin resistant states is normalised by the synthetic retinoid Fenretinide in mice.
Morrice N; Mcilroy GD; Tammireddy SR; Reekie J; Shearer KD; Doherty MK; Delibegović M; Whitfield PD; Mody N
Sci Rep; 2017 Mar; 7():43782. PubMed ID: 28256636
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice.
Zhao C; Liu L; Liu Q; Li F; Zhang L; Zhu F; Shao T; Barve S; Chen Y; Li X; McClain CJ; Feng W
Mol Metab; 2019 Nov; 29():145-157. PubMed ID: 31668386
[TBL] [Abstract][Full Text] [Related]
20. Hepatic Small Ubiquitin-Related Modifier (SUMO)-Specific Protease 2 Controls Systemic Metabolism Through SUMOylation-Dependent Regulation of Liver-Adipose Tissue Crosstalk.
Liu Y; Dou X; Zhou WY; Ding M; Liu L; Du RQ; Guo L; Qian SW; Tang Y; Yang QQ; Pan DN; Li XY; Lu Y; Cheng JK; Tang QQ
Hepatology; 2021 Oct; 74(4):1864-1883. PubMed ID: 33934381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
